» Articles » PMID: 37260462

The Effects of Dual IQOS and Cigarette Smoke Exposure on Airway Epithelial Cells: Implications for Lung Health and Respiratory Disease Pathogenesis

Overview
Journal ERJ Open Res
Specialty Pulmonary Medicine
Date 2023 Jun 1
PMID 37260462
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cigarette smoking remains a primary cause of chronic lung diseases. After a steady decline, smoking rates have recently increased especially with the introduction of newer electronic nicotine delivery devices, and it is also emerging that dual- or poly-product usage is on the rise. Additionally, with the introduction of IQOS (a heated tobacco product) globally, its impact on human health needs to be investigated. In this study we tested if dual exposure (cigarette smoke (CS)+IQOS) is detrimental to lung epithelial cells when compared with CS or IQOS exposure alone.

Methods: Human airway epithelial cells (BEAS-2B) were exposed to either CS, IQOS or their dual combination (CS+IQOS) at concentrations of 0.1%, 1.0%, 2.5% and 5.0%. Cytotoxicity, oxidative stress, mitochondrial homeostasis, mitophagy and effects on epithelial-mesenchymal transition (EMT) signalling were assessed.

Results: Both CS and IQOS alone significantly induced loss of cell viability in a concentration-dependent manner which was further enhanced by dual exposure compared with IQOS alone (p<0.01). Dual exposure significantly increased oxidative stress and perturbed mitochondrial homeostasis when compared with CS or IQOS alone (p<0.05). Additionally, dual exposure induced EMT signalling as shown by increased mesenchymal (α-smooth muscle actin and N-cadherin) and decreased epithelial (E-cadherin) markers when compared with CS or IQOS alone (p<0.05).

Conclusion: Collectively, our study demonstrates that dual CS+IQOS exposure enhances pathogenic signalling mediated by oxidative stress and mitochondrial dysfunction leading to EMT activation, which is an important regulator of small airway fibrosis in obstructive lung diseases.

Citing Articles

The Product Science of Electrically Heated Tobacco Products: An Updated Narrative Review of the Scientific Literature.

Cordery S, Thompson K, Stevenson M, Simms L, Chapman F, Grandolfo E Cureus. 2024; 16(5):e61223.

PMID: 38939262 PMC: 11209752. DOI: 10.7759/cureus.61223.


Heated tobacco product (IQOS) induced pulmonary infiltrates.

Thomas M, Hameed M, Alhadad S, Haq I Respir Med Case Rep. 2024; 49:102026.

PMID: 38712315 PMC: 11070754. DOI: 10.1016/j.rmcr.2024.102026.


RNA sequencing analysis of early-stage atherosclerosis in vascular-on-a-chip and its application for comparing combustible cigarettes with heated tobacco products.

Ohashi K, Hayashida A, Nozawa A, Ito S Curr Res Toxicol. 2024; 6:100163.

PMID: 38571525 PMC: 10987886. DOI: 10.1016/j.crtox.2024.100163.

References
1.
Hoffmann R, Zarrintan S, Brandenburg S, Kol A, de Bruin H, Jafari S . Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cells. Respir Res. 2013; 14:97. PMC: 3852998. DOI: 10.1186/1465-9921-14-97. View

2.
Salman R, Talih S, El-Hage R, Haddad C, Karaoghlanian N, El-Hellani A . Free-Base and Total Nicotine, Reactive Oxygen Species, and Carbonyl Emissions From IQOS, a Heated Tobacco Product. Nicotine Tob Res. 2018; 21(9):1285-1288. PMC: 6698952. DOI: 10.1093/ntr/nty235. View

3.
Guntuku L, Gangasani J, Thummuri D, Borkar R, Manavathi B, Ragampeta S . IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo. Oncogene. 2018; 38(4):581-595. DOI: 10.1038/s41388-018-0446-2. View

4.
Davis B, To V, Talbot P . Comparison of cytotoxicity of IQOS aerosols to smoke from Marlboro Red and 3R4F reference cigarettes. Toxicol In Vitro. 2019; 61:104652. DOI: 10.1016/j.tiv.2019.104652. View

5.
Moazed F, Chun L, Matthay M, Calfee C, Gotts J . Assessment of industry data on pulmonary and immunosuppressive effects of IQOS. Tob Control. 2018; 27(Suppl 1):s20-s25. PMC: 6252496. DOI: 10.1136/tobaccocontrol-2018-054296. View